(Q40494918)

21 September 2017

1 reference

title

Mycobacterium avium complex: advances in therapy (English)

1 reference

Mycobacterium avium avium

21 September 2017

main subject

1 reference

D V Havlir

1

1 reference

21 September 2017

publication date

1 November 1994

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

21 September 2017

published in

1 reference

21 September 2017

volume

13

1 reference

21 September 2017

issue

11

1 reference

21 September 2017

page(s)

915-924

1 reference

The Mycobacterium avium complex

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

An Animal Model of Mycobacterium avium Complex Disseminated Infection after Colonization of the Intestinal Tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Pulmonary infection with nontuberculous mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Progressive disseminated infection with Mycobacterium avium complex after intravenous and oral challenge in cyclosporine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Activity of azithromycin against Mycobacterium avium infection in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

In vitro and in vivo activities of clarithromycin against Mycobacterium avium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Mycobacteria and the new quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02111492

Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature

21 January 2018

1 reference

12 December 2020

Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics

1 reference

12 December 2020

Nontuberculous mycobacteria and associated diseases

1 reference

12 December 2020

Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes

1 reference

12 December 2020

Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information

1 reference

12 December 2020

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Treatment of Disease Due to Mycobacterium intracellulare

1 reference

12 December 2020

Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment.

1 reference

12 December 2020

Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease

1 reference

12 December 2020

Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins

1 reference

12 December 2020

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

1 reference

12 December 2020

Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing

1 reference

12 December 2020

Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.

1 reference

12 December 2020

Long-term results of pulmonary resection for atypical mycobacterial disease

1 reference

12 December 2020

Disseminated Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease

1 reference

12 December 2020

Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

12 December 2020

Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice

1 reference

12 December 2020

Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes

1 reference

12 December 2020

Diagnosis and treatment of disease caused by nontuberculous mycobacteria

1 reference

12 December 2020

Infection with Mycobacterium avium complex in patients without predisposing conditions

1 reference

12 December 2020

Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome

1 reference

12 December 2020

Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.

1 reference

12 December 2020

Factors that Affect the Cell Cycle of Mycobacterium avium

1 reference

12 December 2020

Medical therapy of Mycobacterium avium-intracellulare pulmonary disease

1 reference

12 December 2020

Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age.

1 reference

12 December 2020

An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results

1 reference

12 December 2020

Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

1 reference

12 December 2020

Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients

1 reference

12 December 2020

Comprehensive approach to identification of serovars of Mycobacterium avium complex

1 reference

12 December 2020

Fluconazole and enhanced effect of rifabutin prophylaxis

1 reference

12 December 2020

In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice

1 reference

12 December 2020

Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium

1 reference

12 December 2020

Choice of antimicrobial agents for M. avium disease based on quantitative tests of drug susceptibility

1 reference

12 December 2020

Identification of various serovar strains of Mycobacterium avium complex by using DNA probes specific for Mycobacterium avium and Mycobacterium intracellulare

1 reference

12 December 2020

Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients

1 reference

12 December 2020

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

1 reference

12 December 2020

Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases

1 reference

12 December 2020

Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M kansasii, and M intracellularis infections

1 reference

12 December 2020

Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and from non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M. avium

1 reference

12 December 2020

Mycobacterium avium complex and the normal host: the other side of the coin

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02111492

1 reference

Dimensions Publication ID

21 September 2017

1014838356

0 references

1 reference